Boston Scientific Total Assets increased by 2.3% to $43.67B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 10.9%, from $39.40B to $43.67B. Over 5 years (FY 2020 to FY 2025), Total Assets shows an upward trend with a 7.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Growth in total assets typically mirrors the overall expansion of the business, provided it is accompanied by corresponding revenue growth.
The aggregate value of everything the company owns, including both short-term liquid resources and long-term physical an...
Used to compare the scale of operations across the industry; larger asset bases generally suggest a more dominant market presence.
total_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.17B | $31.88B | $32.23B | $32.34B | $32.19B | $31.95B | $32.47B | $32.89B | $33.60B | $34.04B | $35.14B | $36.67B | $37.11B | $38.08B | $39.40B | $40.14B | $41.56B | $42.71B | $43.67B |
| QoQ Change | — | +2.3% | +1.1% | +0.3% | -0.5% | -0.8% | +1.6% | +1.3% | +2.2% | +1.3% | +3.2% | +4.4% | +1.2% | +2.6% | +3.5% | +1.9% | +3.5% | +2.8% | +2.3% |
| YoY Change | — | — | — | — | +3.3% | +0.2% | +0.7% | +1.7% | +4.4% | +6.6% | +8.2% | +11.5% | +10.4% | +11.9% | +12.1% | +9.5% | +12.0% | +12.2% | +10.9% |